Sorafinot
| Active Ingredient (Generic Name) | Sorafenib 200 mg |
|---|---|
| Indication | Liver cancer, Kidney cancer, Thyroid cancer |
| Manufacturer | Natco Pharma Ltd |
| Packaging | 120 tablets/Bottle |
| Strength | 200 mg |
| Delivery Time | 8 Days |
Sorafenat 200 mg Tablets (Generic Nexavar)
Product Description:
Sorafenat 200 mg is a generic version of Nexavar containing Sorafenib, a targeted anti-cancer drug classified as a multikinase inhibitor. It interferes with the growth and spread of cancer cells by blocking certain proteins that promote cell division and angiogenesis (formation of blood vessels that supply tumors).
This medication is used primarily for the treatment of:
-
Advanced renal cell carcinoma (RCC) – a form of kidney cancer
-
Hepatocellular carcinoma (HCC) – the most common form of liver cancer
Sorafenat may also be prescribed off-label for other malignancies as determined by the treating oncologist.
-
$69.00 - $99.00 -
$79.00 - $181.00
-
$59.00 - $95.00
-
$45.00 - $121.00
-
$95.00 - $200.00
-
$395.00 - $990.00
Reviews & Ratings
Sorafenat 200 mg Tablets (Generic Nexavar)
Product Description:
Sorafenat 200 mg is a generic version of Nexavar containing Sorafenib, a targeted anti-cancer drug classified as a multikinase inhibitor. It interferes with the growth and spread of cancer cells by blocking certain proteins that promote cell division and angiogenesis (formation of blood vessels that supply tumors).
This medication is used primarily for the treatment of:
-
Advanced renal cell carcinoma (RCC) – a form of kidney cancer
-
Hepatocellular carcinoma (HCC) – the most common form of liver cancer
Sorafenat may also be prescribed off-label for other malignancies as determined by the treating oncologist.
Frequently Brought Products
-
$69.00 - $99.00
-
$79.00 - $181.00
-
$59.00 - $95.00
-
$45.00 - $121.00
-
$95.00 - $200.00
-
$395.00 - $990.00
